ArticleVaccines2023

Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers.

Zsolt Matula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.